Cohero Bags $9 Million Series A for Smart Inhalers
Cohero Health said today that it closed a $9 million Series A round for its BreatheSmart patient monitoring platform, which can track medication adherence and measure lung functioning. The funds are also earmarked for commercial development efforts and expanding Cohero’s clinical trial program.
The round was led by Three Leaf Ventures with participation by Zaffre Investments and BioAdvance, Cohero said.
The round was led by Three Leaf Ventures with participation by Zaffre Investments and BioAdvance, Cohero said.